Lyra Therapeutics Inc. (LYRA) Statistics & Valuation Metrics - Stocknear

Lyra Therapeutics Inc.

NASDAQ: LYRA · Real-Time Price · USD
7.02
-0.02 (-0.28%)
At close: Sep 04, 2025, 3:59 PM

Lyra Therapeutics Statistics

Share Statistics

Lyra Therapeutics has 1.64M shares outstanding. The number of shares has increased by 1.24% in one year.

1.64M
1.24%
0.59%
37.95%
1.64M
1,939
1.75%

Short Selling Information

The latest short interest is 50.5K, so 3.07% of the outstanding shares have been sold short.

50.5K
3.07%
3.66%
2.21

Valuation Ratios

The PE ratio is -7.19 and the forward PE ratio is -0.75. Lyra Therapeutics's PEG ratio is -0.53.

-7.19
-0.75
438.05
7.4
57.96
-9.29
-0.53
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Lyra Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.41, with a Debt / Equity ratio of 2.97.

3.41
3.41
2.97
-0.57
-0.48
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$51.13K
$-3.11M
30
0.02
n/a

Taxes

39K
-0.04%

Stock Price Statistics

The stock price has increased by -50.63% in the last 52 weeks. The beta is 0.17, so Lyra Therapeutics's price volatility has been higher than the market average.

0.17
-50.63%
7.93
8.66
44.96
110,733

Income Statement

In the last 12 months, Lyra Therapeutics had revenue of 1.53M and earned -93.44M in profits. Earnings per share was -1.43.

1.53M
1.53M
-96.35M
-93.44M
-60.26M
-60.73M
-1.43
Full Income Statement

Balance Sheet

The company has 40.58M in cash and 34.38M in debt, giving a net cash position of 6.2M.

40.58M
34.38M
6.2M
-404.79M
52.57M
19.9M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.01M and capital expenditures -2.34M, giving a free cash flow of -72.35M.

-70.01M
-2.34M
-72.35M
-1.11
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -6280.83% and -6090.94%.

100%
-6280.83%
-6088.4%
-6090.94%
-3928.42%
-6280.83%
-4716.36%

Dividends & Yields

LYRA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for LYRA is $16, which is 127.3% higher than the current price. The consensus rating is "Hold".

$16
127.3%
Hold
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on May 28, 2025. It was a backward split with a ratio of 1:50.

May 28, 2025
backward
1:50

Scores

-12.81
2